The measure would restrict future stock purchases by members of Congress and their families, while allowing existing holdings to remain. Critics say the presidential exemption leaves a major ethics gap at the center of Washington’s latest reform push.
The House passed the Stop Insider Trading Act, the bill does not apply to President Donald Trump, and the measure was passed 232-198 on Wednesday. The ethics bill is aimed at restricting stock trading by lawmakers and their families, a long-running flashpoint for voters who suspect members of Congress can profit from privileged information.
That combination — a bipartisan-sounding reform vote with a presidential carveout — is why the bill is drawing scrutiny. Republicans promoted it as a serious step beyond disclosure rules, while Democrats, ethics groups and some Republicans criticized what it leaves untouched.
A reform vote with a gap
The Stop Insider Trading Act would not create a blanket government-wide ban on stock trading. Its central target is Congress: members, their spouses and dependent children.
Under the bill, those covered individuals would be barred from purchasing certain investments while in office. The category generally includes individual publicly traded stocks and similar securities, the kinds of holdings most likely to raise questions when lawmakers vote on industries, budgets or regulatory matters.
The House vote, 232-198, was enough to hand supporters a concrete win. A handful of Democrats joined Republicans, giving the measure some bipartisan support even as the broader debate split along familiar lines over whether the legislation is real reform or a narrowed compromise.
The political appeal is easy to see. Congressional stock trading has become one of the rare ethics issues that cuts across party identity. Many voters may disagree on tax rates, regulation or spending, but they tend to dislike the idea that elected officials could use public power and private market positions at the same time.
What the bill would change
The bill would move the rules from after-the-fact disclosure toward limits on future buying. That matters because the current system, shaped by the STOCK Act and congressional ethics rules, relies heavily on reporting transactions after they happen.
Supporters argue disclosure is not enough. If a lawmaker can buy or sell individual stocks while working on legislation that may affect those companies, public notice after the trade does not erase the conflict concern.
The House-passed measure would still allow lawmakers to invest, but not in the same way. The Trump administration, in a Statement of Administration Policy issued Tuesday, said the bill would permit diversified vehicles such as mutual funds and exchange-traded funds rather than bets on specific companies.
The bill also would not force lawmakers to dump stocks they already own. Existing holdings could be retained, and sales would be allowed if advance public notice is filed between seven and 14 days before the transaction.
Why Trump is outside it
The most controversial boundary is who counts as a covered individual. The bill covers members of Congress, spouses and dependent children. It does not include the president or vice president.
That is not a small omission in the current political context. Trump is both the president who would be asked to sign the measure and a public official with extensive financial disclosures that include major holdings and transactions tied to accounts associated with him.
Presidents operate under a separate ethics and disclosure framework from lawmakers. They are not governed by congressional ethics standards in the same way, and they are not generally barred from owning individual stocks.
That legal distinction gives supporters an explanation for the bill’s design. It also gives critics a ready-made objection: if the goal is to reduce conflicts of interest by elected officials, excluding the two highest elected offices in the federal government weakens the claim that the bill is comprehensive.
The White House backs it
The White House endorsed the legislation in its current form. In the administration’s policy statement, Trump’s senior advisers said they would recommend he sign H.R. 7008 if it reached his desk as passed by the House.
The administration framed the bill as stronger than the existing disclosure regime. It said the proposal would prohibit members of Congress and their families from buying individual stocks while in office, require advance disclosure of planned sales and impose substantial penalties for violations.
That message lets the White House align itself with public frustration over congressional stock trading while avoiding a rule that would apply to Trump himself. For critics, that is the central tension: the president can support a ban on congressional trades without accepting the same restriction for the presidency.
Richard Painter, who served as chief White House ethics lawyer under President George W. Bush, told Newsweek he has long supported applying a stock-trading prohibition to members of Congress, the president and the vice president. He still described the House bill as better than nothing, while warning that the exclusion leaves a meaningful gap.
Trump disclosures sharpen scrutiny
The exemption is receiving extra attention because of Trump’s recently disclosed financial activity. Financial disclosures filed with the Office of Government Ethics showed thousands of stock transactions in accounts associated with the president during the first quarter of 2026, involving hundreds of millions of dollars’ worth of securities, according to the reporting behind the bill debate.
Trump’s 2026 annual financial disclosure listed holdings across multiple investment accounts. Reported positions included major publicly traded companies such as Apple, Amazon, Microsoft, Nvidia, Alphabet, Meta, Broadcom, Tesla, Oracle, Palantir, Netflix, JPMorgan Chase and Boeing.
The disclosure also listed significant exchange-traded fund holdings, including funds tied to the S&P 500, technology, growth, financial-sector and bond markets. Some disclosed positions were valued in ranges of $1 million to $5 million, while some major ETF holdings were valued up to $25 million each.
None of that means a violation occurred under existing rules. The issue is broader than legality. Ethics debates often turn on whether public officials should avoid situations that create the appearance of divided loyalties, even when the conduct is permitted.
The fight moves beyond passage
The House vote does not end the debate. The bill still has to clear the rest of the legislative process before becoming law, and any Senate changes could reopen disputes over who should be covered, how strict the restrictions should be and whether existing holdings should be treated differently.
Ethics advocates who want a wider ban are likely to keep pressing on two points. First, they want the president and vice president included. Second, some want lawmakers barred from holding individual stocks at all, not just from buying new ones.
Supporters of the current bill have a different argument: a narrower measure that can pass is more useful than a sweeping proposal that stalls. By that view, stopping future purchases by lawmakers and their immediate families would still mark a real shift in Washington’s ethics rules.
The unresolved question is whether voters will see the bill as meaningful reform or as a carefully drawn line that protects too much. The House has now put a stock-trading restriction on the table. The controversy is over the people left standing outside it.
Leave a Reply